Ahmet Ozdemir
Eskisehir, 26470, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Development of thiazole-hydrazone hybrids for targeted therapy of non-small cell lung cancer.
Journal: Bioorganic chemistry
Published: April 27, 2026
Design, synthesis, in vitro and in silico evaluation of thiazole-hydrazone hybrids as potent and safe α-glucosidase inhibitors.
Journal: Bioorganic chemistry
Published: July 29, 2025
Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy.
Journal: European journal of medicinal chemistry
Published: April 16, 2024
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action.
Journal: International journal of molecular sciences
Published: December 05, 2022
A new series of hydrazones as small-molecule aldose reductase inhibitors.
Journal: Archiv der Pharmazie
Published: November 03, 2022
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer.
Journal: Drug development research
Published: October 12, 2022
Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer.
Journal: European journal of medicinal chemistry
Published: September 06, 2022
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy.
Journal: Molecules (Basel, Switzerland)
Published: December 06, 2021
Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
Journal: Chemico-biological interactions
Published: May 08, 2021
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: October 16, 2020
A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: June 26, 2020
Last Updated: 09/26/2026